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neck pain. METHODS: Patients were recruited by 42
general practitioners if they had been suffering from neck
pain for at least two weeks. The 183 patients were ran-
domly allocated to manual therapy (spinal mobilization,
n  60), physical therapy (exercise therapy and massage,
59), or GP care (counseling, education and medication,
n  64). Clinical outcomes included perceived recovery,
pain intensity, functional disability and quality of life
(EuroQol). Direct and indirect costs were measured by
means of cost diaries completed by patients during the in-
tervention period and the 52-week follow up. Differences
in mean costs between groups were evaluated by apply-
ing non-parametric bootstrapping techniques. RESULTS:
The total costs of the manual therapy (Euro 447) were
approximately one-third of the costs of the physical ther-
apy (Euro 1,297) and GP care (Euro 1,379). These differ-
ences were found to be statistically significant when
bootstrapping was applied. The cost-effectiveness ratios
and the cost-utility ratios showed that manual therapy
was dominant (less costly and more effective), compared
to physical therapy and GP care. The recovery rates
based on perceived recovery after 12 months were 72%
for manual therapy, 63% for physical therapy and 56%
for GP care. With regard to pain intensity and functional
disability, manual therapy was also found to be domi-
nant over time, compared to physical therapy and GP
care, for these clinical outcomes, although the differences
were small. CONCLUSIONS: This study showed that
manual therapy (spinal mobilization) is more effective
and less costly than physical therapy and GP care.
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Upon admission to a skilled nursing home facility, infor-
mation is recorded on a Minimum Data Set (MDS), a
400 item instrument used as the basis of 1) reimburse-
ment for Medicare eligible nursing home stays and 2)
care planning, survey and certification for all nursing
home stays. OBJECTIVE: To predict and evaluate vari-
ables related to hip fractures in the nursing home setting.
METHODS: Electronic MDS data was available from
200 homes for variable evaluation times. The first avail-
able Assessment Reference Date (A3A), was the baseline
for a regression of time to first fracture. Excluded were 1)
patients with a fracture having an A3A date within the
first 10 days of baseline visit, and 2) patients with 60
days of follow-up, from first to last A3A visit. Analysis
included a Kaplan-Meier curve summarizing time to frac-
ture, and a Cox Proportional Hazards regression model.
RESULTS: The initial data set included 23,045 patients.
11,465 met the inclusion criteria, and 336 of these had
fractures. Most important variables, based on the coeffi-
cient size, associated with increasing risk, were unsteady
gait, deterioration in ADL function, a hospital stay in the
last 90 days, use of full bed rails, and Alzheimer’s disease.
The risk was also higher among females and whites. The
need for full physical help while standing had a lower
risk when compared to need for less support, but this is
likely due to a lowered potential for falling, and increased
vigilance an the part of staff. “Deteriorated” ADL func-
tion had almost twice the risk when compared to “im-
proved” ADL. CONCLUSION: Unsteady gait, deteriora-
tion in ADL, use of bed rails, presence of Alzheimer’s
disease, and hospital admissions were associated with an
increased risk of hip fracture. A larger sample of fractures
would be more likely to be successful in studying addi-
tional relationships.
PAM23
VERTEBRAL FRACTURES AMONG 
GLUCOCORTICOID PATIENTS SIGNIFICANTLY 
INCREASE MEDICAL CARE COSTS
Meyer JW1, Burge RT2, Steinbuch M2
1Ingenix Pharmaceutical Services, Eden Prairie, MN, USA; 
2Procter & Gamble Pharmaceuticals, Mason, OH, USA
BACKGROUND: Previous studies have demonstrated
that high levels of glucocorticoid (GC) exposure are asso-
ciated with increased fracture risk. However, none has
reported potential cost impacts. OBJECTIVE: To esti-
mate the marginal costs from vertebral fractures among
GC patients. METHODS: Subjects 18–64 years old with
different GC exposure levels, with and without fractures,
were selected (n  50,191). GC exposure was catego-
rized into three levels: high (3 claims of continuous use
or 9.5 prednisone-equivalent mg/day), low (other GC
use), and no GC use. Fractures, comorbid conditions,
and costs were determined 15 months before and up to
3.5 years after index date. Regression models were used
to estimate the marginal effects of vertebral fractures on
pharmacy costs, medical costs and total costs. The mod-
els controlled for age, gender, pre-index date costs, GC
exposure/fracture combinations, and pre-index and new
post-index date comorbid conditions. RESULTS: Verte-
bral fractures led to significant per-member per-month
(PMPM) cost increases in each GC exposure group. Fur-
thermore, the additional increase in marginal cost from
vertebral fracture on total PMPM costs among high GC
patients versus low GC patients was 83% ($170; p 
0.001). Differential increases in pharmacy and medical
PMPM costs between high and low GC patients were
151% ($56; p  0.01) and 68% ($115; p  0.014), re-
spectively. CONCLUSIONS: Vertebral fractures were as-
sociated with increased PMPM costs, holding constant
patients’ underlying conditions. High GC patients had
greater PMPM increases from vertebral fractures com-
